Head Early Development Capabilities and Alliances
Reneé Smith, MBA has over 25 years of experience in research and healthcare. Reneé is currently the Head, Early Development Oncology Capabilities and Alliances at Janssen Pharmaceuticals. Prior to Janssen, she held the role of Associate Vice President, Global Quality and Education at Sarah Cannon where she greatly expanded Sarah Cannon’s quality infrastructure and training and education resources with oversight of the research and blood cancer network quality program as well as the contract research organization.
Reneé currently is a member of the AACI Corporate Roundtable representing Janssen and is a working group member for the Society of Clinical Research Sites (SCRS) focusing on Early Development education for clinical sites. Renee’ previously served as a Council Member on the American Society of Clinical Oncology (ASCO) Research Community Forum and has served on various working groups with the ASCO Research Community Forum. Additionally, she has participated in research-focused working groups with the Clinical Trials Transformation Initiative and the National Academies of Sciences, Engineering and Medicine.